# Topical Timolol 0.5% Solution for Proliferating Infantile Hemangiomas

> **NCT01147601** · EARLY_PHASE1 · TERMINATED · sponsor: **Oregon Health and Science University** · enrollment: 6 (actual)

## Conditions studied

- Hemangioma
- Infant

## Interventions

- **DRUG:** topical 0.5% Timolol
- **DRUG:** Control (placebo) group

## Key facts

- **NCT ID:** NCT01147601
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-03
- **Primary completion:** 2012-10
- **Final completion:** 2014-08
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2017-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01147601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01147601, "Topical Timolol 0.5% Solution for Proliferating Infantile Hemangiomas". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT01147601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*